More

    Top Chinese drugmaker Hengrui soars in Hong Kong trading debut



    [

    Hengrui’s debut, which comes on the heels of CATL’s blockbuster Hong Kong premiere, builds on Hong Kong’s hot listings market—where proceeds are forecast to double to more than $22 billion this year.

    Hengrui’s debut, which comes on the heels of CATL’s blockbuster Hong Kong premiere, builds on Hong Kong’s hot listings market—where proceeds are forecast to double to more than $22 billion this year.

    May James—SOPA Images/LightRocket via Getty Images

    https://fortune.com/img-assets/wp-content/uploads/2025/05/GettyImages-2209023519-e1747984384247.jpg?resize=1200,600
    https://fortune.com/asia/2025/05/23/top-chinese-drugmaker-hengrui-soars-in-hong-kong-trading-debut/


    Amber Tong, Bloomberg

    Latest articles

    spot_imgspot_img

    Related articles

    Leave a reply

    Please enter your comment!
    Please enter your name here

    spot_imgspot_img